Stocks and Finance

DepoMed

DepoMed 1/24/2012

19:00 : Specialty pharmaceutical company Depomed (DEPO) says it's initiated Phase - Specialty pharmaceutical company Depomed (DEPO) says it's initiated Phase 2 clinical trials of DM-1992 in patients with advanced Parkinson's disease. Shares +3.8% AH. Post your comment!
Source : seekingalpha-com

DepoMed 10/13/2011

18:04 : Shares of Depomed (DEPO) get clobbered in the post trading session after ... - Shares of Depomed (DEPO) get clobbered in the post trading session after the company says top-line results from its Phase 3 trial evaluating the efficacy and safety of Serada, a drug for menopausal hot flashes, missed on a key secondary ...
Source : seekingalpha-com
17:20 : Depomed hot flashes drug fails in Phase III trial - Shares of drug developer Depomed Inc. tanked in after-hours trading Thursday after the company said a trial of its experimental hot flashes drug failed to decrease the number of attacks after 12 and 24 weeks of treatment. The stock of Menlo ...
Source : bizjournals-com

DepoMed 8/24/2011

11:03 : Shares of DepoMed gain 5.7%, helped along with insider buying from the ... - Shares of DepoMed gain 5.7%, helped along with insider buying from the firm's CEO. Earlier this week, the specialty pharmaceutical company announced a new agreement with Santarus (SNTS +1.4%) to market its Glumetza diabetes ...
Source : seekingalpha-com
actualidad DepoMed -


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts